Molecular Epidemiology of Acute Myelogenous Leukemia
Anahtar kelimeler
Öz
Açıklama
INFORMED CONSENTS FOR AML PATIENTS:
For this study, participant will be asked to complete a personal interview. During the interview, participant will be asked questions about participant's demographics (age, sex, etc.), any chemicals participant may have been exposed to, participant's medical history, family history of cancer, participant's diet, and participant's smoking and alcohol use histories. It should take around 50 minutes to complete the interview.
Participant will also have around 1 tablespoon of blood drawn for special tests. These tests will look for any biologic factors associated with AML.
The interview and the blood draw may be done during a regularly scheduled visit to M. D. Anderson, or may be scheduled at the time and place of participant's convenience.
Participant may be contacted at home by phone so that researchers can collect information about any changes in participant's health status.
This is an investigational study. Up to 1,200 participants will take part in this study.
INFORMED CONSENT FOR CONTROL SUBJECTS:
For this study, participant will be asked to complete a personal interview. During the interview, participant will be asked questions about participant's demographics (age, sex, etc.), any chemicals participant may have been exposed to, participant's medical history, family history of cancer, participant's diet, and participant's smoking and alcohol use histories. It should take around 50 minutes to complete the interview.
Participant will also have around 1 tablespoon of blood drawn for special tests. These tests will look for any biologic factors associated with AML. The interview and blood draw will be scheduled at the time and place of participant's convenience.
This is an investigational study. Up to 1,200 participants will take part in this study.
Tarih
| Son Doğrulandı: | 12/31/2019 |
| İlk Gönderilen: | 07/15/2007 |
| Tahmini Kayıt Gönderildi: | 07/16/2007 |
| İlk Gönderilen: | 07/17/2007 |
| Son Güncelleme Gönderildi: | 01/08/2020 |
| Son Güncelleme Gönderildi: | 01/12/2020 |
| Fiili Çalışma Başlangıç Tarihi: | 06/22/2003 |
| Tahmini Birincil Tamamlanma Tarihi: | 09/29/2020 |
| Tahmini Çalışma Tamamlanma Tarihi: | 09/29/2020 |
Durum veya hastalık
Müdahale / tedavi
Behavioral: Interview
Evre
Kol Grupları
| Kol | Müdahale / tedavi |
|---|---|
| Interview AML Patients & Healthy Controls | Behavioral: Interview Interview lasting approximately 50 minutes. |
Uygunluk kriterleri
| Çalışmaya Uygun Yaşlar | 18 Years İçin 18 Years |
| Çalışmaya Uygun Cinsiyetler | All |
| Örnekleme yöntemi | Non-Probability Sample |
| Sağlıklı Gönüllüleri Kabul Ediyor | Evet |
| Kriterler | Inclusion Criteria: 1. A histologically confirmed diagnosis of AML (patients only) 2. Aged 18 or older 3. Resident of Texas 4. Willing and able to provide written informed consent and authorization 5. Willing to donate 10mL of blood and complete a personal interview Exclusion Criteria: 1. Under 18 years of age 2. History of invasive cancer, excluding non-melanoma skin cancer (controls only) |
Sonuç
Birincil Sonuç Ölçütleri
1. Identify biologic and lifestyle factors that may increase a person's risk of developing acute myelogenous leukemia. [8 Years]
